Advertisement
U.S. markets closed
  • S&P Futures

    5,208.25
    -6.50 (-0.12%)
     
  • Dow Futures

    39,202.00
    -21.00 (-0.05%)
     
  • Nasdaq Futures

    18,186.75
    -44.75 (-0.25%)
     
  • Russell 2000 Futures

    2,047.50
    -2.30 (-0.11%)
     
  • Crude Oil

    82.60
    -0.12 (-0.15%)
     
  • Gold

    2,164.60
    +0.30 (+0.01%)
     
  • Silver

    25.33
    +0.07 (+0.26%)
     
  • EUR/USD

    1.0877
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    4.3400
    +0.0360 (+0.84%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • GBP/USD

    1.2724
    -0.0005 (-0.04%)
     
  • USD/JPY

    149.2950
    +0.1970 (+0.13%)
     
  • Bitcoin USD

    65,869.38
    -1,982.66 (-2.92%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    39,596.29
    -144.15 (-0.36%)
     

ETF Winners of the First Year of Trump Era

Zacks.com featured highlights include: Twitter, Lockheed Martin, Intercontinental Exchange, CBRE and Keurig Dr Pepper

Donald Trump is nearing his best political day in life (probably). He became the U.S. President on Nov 8, 2016 and prompted a monster rally in the U.S. stock market. The Dow Jones Industrial Average has been one of the strongest beneficiaries of the Trump rally with DIA gaining about 28% since his election win (as of Nov 2, 2017).

His promises of tax cuts, deregulations in the financial sector and bringing back foreign jobs to America boosted the markets. The S&P 500-based ETF SPY added over 20% while the Nasdaq-100-based fund QQQ surged about 30% during this time frame. Along with Trump bump, a harmonized recovery in the global economy also led such gigantic gains. 

While Trump’s several agenda faced political gridlocks, and have not seen the day of the light yet, markets remain upbeat. All hopes have not died yet. Against this backdrop, we would like to highlight ETFs that have performed superbly since Trump’s win (read: Welcome Trump Era with These ETFs).

 ARK Innovation ETF ARKK – Up 74.2%

Companies in ARKK include those that “benefit from the development of new products or services, technological improvements and advancements in scientific research” (read: ETFs Riding High On Bitcoin Surge).

 ARK Web x.0 ETF ARKW – Up 72.9%

The ARK Web x.0 ETF looks to track the long-term growth of capital. It is an actively managed ETF that invests primarily in domestic equity securities and U.S. exchange traded foreign equity securities of companies that are related to the fund’s investment theme of Web x.0 (read: Twitter Surges on Q3 Results: Log in to These ETFs).

PowerShares Dynamic Semiconductors ETF PSI – Up 61.6%

Semiconductor stocks had every reason to put up a great show. Rise in cloud computing, surge of bitcoins and upbeat forecast for electronics sales in the holiday season — all call for greater demand for semiconductors. Apart from PSI, other semiconductor ETFs like First Trust Nasdaq Semiconductor ETF FTXL and VanEck Vectors Semiconductor ETF SMH also surged (read: 5 Biggest ETF Winners of Trump Trade Resurgence).

Global X Lithium & Battery Tech ETF LIT – Up 60.9%

The fund looks to track the performance of the companies that are active in the exploration and/ or mining of Lithium or production of Lithium batteries. The fund surged as electric-powered vehicles are gaining immense popularity (read: Inside The Surge in Lithium ETF).

Global X Robotics & Artfcl Intllgnc ETF BOTZ – Up 56.5%

The product invests in companies that are set to benefit from increased utilization of robotics and artificial intelligence (read: Inside the Rise of Thematic ETFs).

iShares U.S. Home Construction ETF ITBUp 51.7%

The housing sector has been in good shape. The fund looks to track the performance of the home construction sector of the U.S. equity market (read: 5 ETFs to Soar After Solid Q3 GDP Data).

PowerShares DWA Healthcare Momentum ETF PTH – Up 50.8%

This segment also caught investors’ attention. Healthcare was hit hard before election on the price-gouging issue. The issue was first raised by Hillary Clinton in September 2015 and since then the space has been battered by increasing political and media focus on high prices for some drugs.

However, the stringent approach is easing, allowing investors to enter the space all over again. Also, President Trump’s pledges to reduce FDA regulations, removal of taxes and fees on pharmaceutical and medical-device manufacturers, and successful clinical trials  for new drugs may prove to be a boon to the space (read: 5 Reasons Why Biotech ETFs are Soaring).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
SPDR-DJ IND AVG (DIA): ETF Research Reports
 
NASDAQ-100 SHRS (QQQ): ETF Research Reports
 
SPDR-SP 500 TR (SPY): ETF Research Reports
 
ISHARS-US HO CO (ITB): ETF Research Reports
 
PWRSH-DYN SEMI (PSI): ETF Research Reports
 
VANECK-SEMICON (SMH): ETF Research Reports
 
ARK- WEB XO ETF (ARKW): ETF Research Reports
 
PWRSH-DW HLT MO (PTH): ETF Research Reports
 
ARK-INNOVATION (ARKK): ETF Research Reports
 
GLBL-X LITHIUM (LIT): ETF Research Reports
 
FT-NDQ SEMICON (FTXL): ETF Research Reports
 
GLBL-X ROB&ART (BOTZ): ETF Research Reports
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Advertisement